J&J, Novoste Receive Simultaneous Approval For Brachytherapy Devices

FDA's Nov. 3 approval of Novoste's Beta-Cath and Johnson & Johnson/Cordis' Checkmate intravascular brachytherapy systems for treating in-stent restenosis come in time for the firms to unveil their devices at the upcoming American Heart Association scientific sessions, scheduled for Nov. 12-15 in New Orleans.